Landon Jackson (Football Recruiting, 2021)
Story Poster
2021 DE Landon Jackson Remains Interested In Irish
4 yr ago by Christian McCollum
Big-time 2021 Texas defensive end Landon Jackson says he's still in touch with Notre Dame and is considering another visit to South Bend.
Story Poster
8:10
ISD Video | Under Armour Future 50 Highlights
4 yr ago by Christian McCollum
Highlights the Future 50 at the Under Armour All-America Game
Story Poster
Heat Check | 2021 Defense
4 yr ago by Matt Freeman
A quick rundown of where Notre Dame stands with the 2021 prospects who have an offer from the Irish.
Story Poster
Rivals Top 100 Released
4 yr ago by Matt Freeman
Notre Dame was well represented in the updated Top100 for the 2021 class.
Story Poster
Safe Travels | Notre Dame Targets Visiting Elsewhere
4 yr ago by Christian McCollum
A look at where some of Notre Dame's top underclassman targets will be visiting this weekend.
Story Poster
2021 ESPN 300 Released
4 yr ago by Matt Freeman
ESPN released its top 300 for the 2021 class on Wednesday.
Author
Top 2021 DE Releases Top 10
4 yr ago by Matt Freeman
Story Poster
Thoughts on the Rivals 100 for 2021
4 yr ago by Matt Freeman
Notre Dame is very relevant in the initial Rivals 100 for the 2021 recruiting class.
Author
Safe Travels | ND Prospects Visiting Elsewhere | 4/12
4 yr ago by Christian McCollum
Story Poster
2021 Texarkana DE Landon Jackson Fired Up For Notre Dame Offer
4 yr ago by Matt Freeman
2021 Pleasant Grove (Texas) defensive end Landon Jackson discusses his offer from Notre Dame.
Story Poster
New Offer | 2021 TX DE Landon Jackson
4 yr ago by Matt Freeman
Notre Dame has offered 2020 Pleasant Grove (Texas) defensive end Landon Jackson
Story Poster
Notre Dame To Host Top 2021 Texas Defensive End
5 yr ago by Matt Freeman
2021 Pleasant Grove (Texas) defensive end Landon Jackson has set a visit to Notre Dame later this month.
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.